Coagulation status and biochemical and inflammatory markers in multiple sclerosis

Journal of Clinical Neuroscience

Volumn 15, Issue 4, 2008, Pages 393-397

  Aksungar, Fehime B ^a   Topkaya, Aynur E ^a   Yildiz, Zeynep ^b   Sahin, Sevki ^a   Turk, Ulku ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b Kartal Lutfi Kirdar Training and Research Hospital   (Turkey)

Author keywords

Coagulation; CRP; D dimer; Fibrinogen; Homocysteine; MS

Indexed keywords

ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; D DIMER; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; NITROGEN; PROTHROMBIN; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPREHENSION; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HUMAN; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; BLOOD COAGULATION FACTORS; BLOOD UREA NITROGEN; C-REACTIVE PROTEIN; CALCIUM; CREATININE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; TIME FACTORS;

EID: 39649083337     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.02.090     Document Type: Article

References (31)

1. Charcot J. Comptes rendus des ce'nces et mémoires lus a la société de Biologie. (1868)
2. Charcot J. Histologie de la sclérose en plaque. Gazette des Hospitaux 41 (1868) 554-566
3. Hafler D.A. Multiple sclerosis. J Clin Invest 113 (2004) 788-794
4. Sorensen P.S. Multiple sclerosis: pathophysiology revisited. Lancet Neurol 4 (2005) 9-10
5. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
6. Akkasoglu K., and Strickland S. Nervous system pathology: the fibrin perspective. Biol Chem 838 (2002) 37-45
7. Matsuo T., Kobayashi H., Kairo K., et al. Fibrin D-dimer in thrombogenic disorders. Semin Thromb Hemost 26 (2000) 101-117
8. Twardowska E.Z., and Wajgt A. Blood levels of selected hormones in patients with sclerosis. Med Sci Monit 7 (2001) 1005-1012
9. Gveric D., Herrera B., Petzold A., et al. Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. Brain 126 (2003) 1590-1598
10. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
11. Fazekas F., Strasser-Fuchs S., Kollegger H., et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57 (2001) 853-857
12. Vrethem M., Mattsson E., Hebelka H., et al. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebospinal fluid homocyteine and methylmalonic acid. Mult Scler 9 (2003) 239-245
13. Baig S.M., and Qureshi G. Homocysteine and vitamin B12 in multiple sclerosis. Biogenic Amines 11 (1995) 479-485
14. Hvas A.M., Ellegard J., and Nexo E. Increased plasma methylmalonic acid levels does not predict clinical manisfestions of vitamin B12 deficiency. Arch Intern Med 161 (2001) 1534-1541
15. Krumdieck C.L., and Prince C.W. Mechanisms of homocysteine toxicity on connective tissues: Implications for the morbidity of aging. J Nutr 130 (2000) 365-368
16. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 130 (2000) 377-381
17. Chandler W.L., Alessi M.C., Aillaud M.F., et al. Formation, inhibition and clearence of plasmin in vivo. Haemostasis 30 (2000) 204-218
18. Calabresi P., Napolitano M., Centonze D., et al. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12 (2000) 1002-1012
19. Strickland S. Tissue plasminogen activator in nervous system function and dysfunction. Thromb Haemost 86 (2001) 138-143
20. Siconolfi L.B., and Seeds N.W. Mice lacking tPA, uPA or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21 (2001) 4348-4355
21. Wakefield A.J., More L.J., Difford J., et al. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47 (1994) 129-133
22. Kuch B., Bobak M., Fobker M., et al. Associations between homocysteine and coagulation factors-a cross-sectional study in two populations of central Europe. Thromb Res 103 (2001) 265-273
23. Klerk M., Verhoef P., Verbruggen B., et al. Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation. Thromb Haemost 88 (2002) 230-235
24. Sciacca F.L., Ciusani E., Silvani A., et al. Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res 10 (2004) 1312-1317
25. Ramsaransing G.S., Fokkema M.R., Teelken A., et al. Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 77 (2006) 189-192
26. Iwasaki Y., and Kinoshita M. Thyroid function in patients with multiple sclerosis. Acta Neurol Scand 77 (1998) 269
27. Zych-Twardowska E., and Wajgt A. Blood levels of selected hormones in patients with multiple sclerosis. Med Sci Monit 7 (2001) 1005-1012
28. Klapps P., Seyfert S., Fischer T., et al. Endocrine function in multiple sclerosis. Acta Neurol Scand 85 (1992) 353-357
29. Noseworthy J.H., Luchinetti C., Rodriguez M., et al. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
30. Giovannoni G., Thorpe J.W., Kidd D., et al. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry 60 (1996) 20-26
31. Soilu-hannien M., Koskinen J.O., Laaksonen M., et al. High sensitivity measurement of CRP and disease progression in multiple sclerosis. Neurology 65 (2005) 153-155